Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.34 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.34 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.34 |
| ▸ | CTSL | P07711 | 1/20 | 0.33 |
| ▸ | CTSB | P07858 | 1/20 | 0.33 |
| ▸ | CTSK | P43235 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.33 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19540992 | 0.88 | ALDH1A1 (0.33) | LMNA | |
| SCHEMBL23675573 | 0.88 | ALDH1A1 (0.33) | LMNA | |
| SCHEMBL23675571 | 0.88 | ALDH1A1 (0.33) | LMNA | |
| SCHEMBL28647347 | 0.80 | ESR1 (0.31) | — | |
| SCHEMBL6081993 | 0.79 | ALDH1A1 (0.55) | LMNAEPHX1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL15608263 | 0.79 | ALDH1A1 (0.55) | LMNAEPHX1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL8408212 | 0.79 | ALDH1A1 (0.55) | LMNAEPHX1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL23493948 | 0.79 | ALDH1A1 (0.55) | LMNAEPHX1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL5936685 | 0.79 | ALDH1A1 (0.55) | LMNAEPHX1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL105131 | 0.79 | ALDH1A1 (0.55) | LMNAEPHX1SLC1A3SLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7858670-B2 | Photosensitive inkjet ink | TOSHIBA TEC KABUSHIKI KAISHA (JP) | 2010-12-28 | — | — | US | disclosed |
| US-7858670-B2 | Photosensitive inkjet ink | TOSHIBA TEC KABUSHIKI KAISHA (JP) | 2010-12-28 | — | — | US | disclosed |
| US-7745438-B2 | 3-(2-acylamino-1-hydroxyethyl)-morpholine derivatives and their use as bace inhibitors | ELI LILLY AND COMPANY (US) | 2010-06-29 | — | — | US | disclosed |
| US-20100026771-A1 | INKJET RECORDING METHOD, INKJET RECORDING SYSTEM, AND PRINTED MATERIAL | FUJIFILM CORPORATION (JP) | 2010-02-04 | — | — | US | disclosed |
| US-20100026771-A1 | INKJET RECORDING METHOD, INKJET RECORDING SYSTEM, AND PRINTED MATERIAL | FUJIFILM CORPORATION (JP) | 2010-02-04 | — | — | US | disclosed |
| EP-2149457-A2 | Inkjet recording method, inkjet recording system, and printed material | Fujifilm Corporation (JP) | 2010-02-03 | — | — | EP | disclosed |
| US-20090234040-A1 | ACTIVE ENERGY RAY-CURABLE INK COMPOSITION, STORAGE CONTAINER FOR ACTIVE ENERGY RAY-CURABLE INK COMPOSITION, AND METHOD FOR STORING ACTIVE ENERGY RAY-CURABLE INK COMPOSITION | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2009-09-17 | — | — | US | disclosed |
| US-20090234040-A1 | ACTIVE ENERGY RAY-CURABLE INK COMPOSITION, STORAGE CONTAINER FOR ACTIVE ENERGY RAY-CURABLE INK COMPOSITION, AND METHOD FOR STORING ACTIVE ENERGY RAY-CURABLE INK COMPOSITION | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2009-09-17 | — | — | US | disclosed |
| US-7473720-B2 | Photosensitive inkjet ink | TOSHIBA TEC KABUSHIKI KAISHA (JP) | 2009-01-06 | — | — | US | disclosed |
| US-7473720-B2 | Photosensitive inkjet ink | TOSHIBA TEC KABUSHIKI KAISHA (JP) | 2009-01-06 | — | — | US | disclosed |
| US-7375145-B2 | capable of overcoming the problems such as poor cation polymerizing reaction and solvent resistance which are particularly accompanied with the conventional photosensitive inkjet ink containing, as a main component, a vinyl ether compound | TOSHIBA TEC KABUSHIKI KAISHA (JP) | 2008-05-20 | — | — | US | disclosed |
| EP-1528088-B1 | Inkjet ink | TOSHIBA TEC KK (JP) | 2008-02-27 | — | — | EP | disclosed |
| US-20070270520-A1 | Capable of overcoming the problems such as poor cation polymerizing reaction and solvent resistance which are particularly accompanied with the conventional photosensitive inkjet ink containing, as a main component, a vinyl ether compound | RISO TECHNOLOGIES CORPORATION (JP) | 2007-11-22 | — | — | US | disclosed |
| US-20070270520-A1 | Capable of overcoming the problems such as poor cation polymerizing reaction and solvent resistance which are particularly accompanied with the conventional photosensitive inkjet ink containing, as a main component, a vinyl ether compound | RISO TECHNOLOGIES CORPORATION (JP) | 2007-11-22 | — | — | US | disclosed |
| US-20070225267-A1 | 3-(2-Acylamino-1-Hydroxyethyl)-Morpholine Derivatives and Their Use as Bace Inhibitors | ELI LILLY AND COMPANY | 2007-09-27 | — | — | US | disclosed |
| US-20070185224-A1 | PHOTOSENSITIVE INKJET INK | KABUSHIKI KAISHA TOSHIBA (JP) | 2007-08-09 | — | — | US | disclosed |
| US-20070185224-A1 | PHOTOSENSITIVE INKJET INK | KABUSHIKI KAISHA TOSHIBA (JP) | 2007-08-09 | — | — | US | disclosed |
| US-20070101898-A1 | Inkjet ink | AKIYAMA RYOZO | 2007-05-10 | — | — | US | disclosed |
| US-20070101898-A1 | Inkjet ink | AKIYAMA RYOZO | 2007-05-10 | — | — | US | disclosed |
| WO-2003062265-A2 | NOVEL PEPTIDES AS NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS | SCHERING CORPORATION (US) | 2003-07-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070225267-A1 | 3-(2-Acylamino-1-Hydroxyethyl)-Morpholine Derivatives and Their Use as Bace Inhibitors | BACE1, BACE2, APP | LMNA 877/4885EPHX1 209/4885SLC1A3 772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.